Holen Sie sich die Stockscreener-App
2.36
2.48%
-0.06
Schlusskurs vom Vortag:
$2.42
Offen:
$2.43
24-Stunden-Volumen:
22,215
Relative Volume:
0.18
Marktkapitalisierung:
$27.32M
Einnahmen:
$996.00K
Nettoeinkommen (Verlust:
$-6.09M
KGV:
-4.4528
EPS:
-0.53
Netto-Cashflow:
$-9.76M
1W Leistung:
+3.06%
1M Leistung:
+12.38%
6M Leistung:
+103.45%
1J Leistung:
+129.13%
1-Tages-Spanne:
$2.33
$2.51
1-Wochen-Bereich:
$2.26
$2.54
52-Wochen-Spanne:
$0.72
$2.95
Therapeuticsmd Inc Stock (TXMD) Company Profile
Firmenname
Therapeuticsmd Inc
Sektor
Telefon
561-961-1900
Adresse
951 YAMATO ROAD, SUITE 220, BOCA RATON, FL
Compare TXMD vs TAK, ZTS, HLN, TEVA, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TXMD
Therapeuticsmd Inc
|
2.36 | 28.01M | 996.00K | -6.09M | -9.76M | -0.53 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.46 | 58.03B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
126.65 | 55.37B | 9.40B | 2.65B | 2.24B | 5.935 |
|
HLN
Haleon Plc Adr
|
11.20 | 49.70B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
33.98 | 39.50B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
473.66 | 20.50B | 3.13B | 1.27B | 1.12B | 26.39 |
Therapeuticsmd Inc Stock (TXMD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2020-08-07 | Herabstufung | Jefferies | Hold → Underperform |
| 2020-05-19 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2019-12-02 | Eingeleitet | Guggenheim | Buy |
| 2019-10-17 | Eingeleitet | H.C. Wainwright | Buy |
| 2019-04-30 | Fortgesetzt | Noble Capital Markets | Outperform |
| 2018-06-15 | Eingeleitet | JP Morgan | Overweight |
| 2017-09-08 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2017-07-11 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2017-05-09 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2016-11-22 | Fortgesetzt | Jefferies | Buy |
| 2016-11-22 | Eingeleitet | Oppenheimer | Outperform |
| 2016-11-07 | Fortgesetzt | Guggenheim | Buy |
| 2016-04-04 | Eingeleitet | Goldman | Buy |
| 2015-12-08 | Bestätigt | Jefferies | Buy |
| 2015-12-08 | Bestätigt | Stifel | Buy |
| 2015-09-21 | Bestätigt | Jefferies | Buy |
| 2015-06-09 | Eingeleitet | Guggenheim | Buy |
| 2014-07-08 | Eingeleitet | FBR Capital | Outperform |
| 2014-04-17 | Bestätigt | Noble Financial | Buy |
| 2014-01-28 | Bestätigt | Noble Financial | Buy |
Alle ansehen
Therapeuticsmd Inc Aktie (TXMD) Neueste Nachrichten
Is TherapeuticsMD Inc. stock a buy or sell2025 Retail Activity & Daily Profit Maximizing Trade Tips - mfd.ru
Aug Breakouts: Can JetAI Inc be the next market leaderWeekly Gains Report & Risk Managed Investment Signals - baoquankhu1.vn
Should you buy the dip on TherapeuticsMD Inc.Dividend Hike & Daily Momentum Trading Reports - mfd.ru
Why TherapeuticsMD Inc. stock could rally in 2025Breakout Watch & High Conviction Investment Ideas - bollywoodhelpline.com
Momentum Shift: Is TherapeuticsMD Inc stock a falling knife or bargain buyGap Down & Weekly High Return Stock Opportunities - baoquankhu1.vn
Is TherapeuticsMD Inc forming a double bottomEarnings Trend Report & Reliable Trade Execution Plans - baoquankhu1.vn
Sell Signal: What is the fair value of TherapeuticsMD Inc stock nowMarket Performance Report & Verified Momentum Stock Watchlist - Bộ Nội Vụ
Gains Recap: Why retail investors pile into TherapeuticsMD Inc stockRate Hike & Daily Volume Surge Signals - Bộ Nội Vụ
Portfolio Shifts: Is TherapeuticsMD Inc stock heavily shortedMarket Sentiment Report & Growth Focused Stock Pick Reports - baoquankhu1.vn
Institution Moves: How strong is TherapeuticsMD Inc stock revenue growthJuly 2025 Outlook & Reliable Entry Point Alerts - Bộ Nội Vụ
TherapeuticsMD Reports Q3 2025 Financial Results - MSN
Why TherapeuticsMD Inc. stock could be next big winnerShare Buyback & Accurate Buy Signal Alerts - Улправда
Is TherapeuticsMD Inc. stock a buy for dividend growthCPI Data & Weekly Setup with ROI Potential - Улправда
Will TherapeuticsMD Inc. stock continue upward momentum2025 Trade Ideas & Stepwise Trade Execution Plans - Улправда
Is TherapeuticsMD Inc. stock a safe haven asset2025 Performance Recap & Free Community Consensus Stock Picks - Улправда
Can TherapeuticsMD Inc. stock rebound after recent weaknessChart Signals & Smart Investment Allocation Tips - Улправда
Can TherapeuticsMD Inc. stock deliver strong Q4 earningsJuly 2025 EndofMonth & Community Trade Idea Sharing - Улправда
Chart Watch: Can TherapeuticsMD Inc. stock deliver strong Q4 earningsQuarterly Profit Report & Weekly Top Gainers Trade List - Улправда
How strong is TherapeuticsMD Inc. stock revenue growthTreasury Yields & Technical Pattern Recognition Alerts - Улправда
Analysis Recap: Why TherapeuticsMD Inc. stock could be next big winner2025 Key Lessons & Detailed Earnings Play Strategies - Улправда
Will TherapeuticsMD Inc. stock deliver long term returnsFibonacci Extensions & Easy Tools to Analyze Your Investment Risk - Улправда
EQUITY ALERT: Lundin Law PC Announces a Securities Class Action Lawsuit against TherapeuticsMD, Inc. and Reminds Investors with Losses to Contact the Firm - ACCESS Newswire
Fund Flows: Why TherapeuticsMD Inc stock could be next big winnerMarket Sentiment Review & Stepwise Entry/Exit Trade Alerts - Bộ Nội Vụ
TherapeuticsMD Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
TherapeuticsMD Inc. Stock Slips 3.4%, Underperforms Market - 富途牛牛
TherapeuticsMD Inc. stock outperforms competitors on strong trading day - MarketWatch
TherapeuticsMD approves key proposals at annual meeting - MSN
TherapeuticsMD Inc. Stock Rallies 3.7%, Outperforms Market - 富途牛牛
TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day - 富途牛牛
TherapeuticsMD Inc. stock underperforms Monday when compared to competitors - MarketWatch
How Low Can TherapeuticsMD Stock Really Go? - Trefis
Why hedge funds are buying TherapeuticsMD Inc. stockWeekly Trade Report & Intraday High Probability Setup Alerts - Улправда
Rate Cut: Will TherapeuticsMD Inc. stock deliver long term returnsEarnings Overview Report & AI Powered Market Entry Strategies - Улправда
MSN Money - MSN
TherapeuticsMD Earnings Notes - Trefis
Block Trades: How currency fluctuations impact TherapeuticsMD Inc. stock2025 Momentum Check & Advanced Technical Analysis Signals - ulpravda.ru
How supply chain issues affect TherapeuticsMD Inc. stockJuly 2025 Highlights & Long-Term Capital Growth Strategies - Улправда
Dilution adjustment of TherapeuticsMD, Inc. – FWB:29TA - TradingView — Track All Markets
TherapeuticsMD Approves Key Proposals at Annual Meeting - TipRanks
TherapeuticsMD (NASDAQ: TXMD) investors approve 2025 votes, 640M share authorization - Stock Titan
Price to earnings ratio of TherapeuticsMD, Inc. – DUS:29TA - TradingView — Track All Markets
29TA Stock Price and Chart — DUS:29TA - TradingView — Track All Markets
TherapeuticsMD Inc. Stock Underperforms Friday When Compared To Competitors - 富途牛牛
TherapeuticsMD Inc. stock underperforms Friday when compared to competitors - MarketWatch
TherapeuticsMD Inc. Stock Underperforms Thursday When Compared To Competitors - 富途牛牛
TherapeuticsMD Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Dip Buying: Is TherapeuticsMD Inc stock attractive for income investorsIPO Watch & AI Based Trade Execution Alerts - moha.gov.vn
With TherapeuticsMD Stock Surging, Have You Considered The Downside? - Trefis
TherapeuticsMD (TXMD) Stock Analysis Report | Financials & Insights - Benzinga
TherapeuticsMD, Inc. (TXMD) -6.3% in After-hours: Price Decline Despite Recent Results - Stocks Telegraph
Will TherapeuticsMD Inc. (29TA) stock profit from automation waveEarnings Miss & Weekly Watchlist of Top Performers - Newser
Finanzdaten der Therapeuticsmd Inc-Aktie (TXMD)
Umsatz
Nettogewinn
Free Cashflow
ENV
Therapeuticsmd Inc-Aktie (TXMD) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Thompson Tommy G | Director |
Apr 14 '25 |
Buy |
1.00 |
325 |
326 |
14,779 |
| Walker Marlan D | Chief Executive Officer |
Apr 14 '25 |
Buy |
1.00 |
490 |
489 |
73,639 |
| Walker Marlan D | Chief Executive Officer |
Apr 10 '25 |
Buy |
0.86 |
1,167 |
1,000 |
73,149 |
| Walker Marlan D | Chief Executive Officer |
Apr 09 '25 |
Buy |
0.87 |
1,136 |
994 |
71,982 |
| Collins Cooper C. | Director |
Feb 18 '25 |
Option Exercise |
0.00 |
8,500 |
0 |
60,516 |
| Naughton Gail K | Director |
Feb 18 '25 |
Option Exercise |
0.00 |
8,500 |
0 |
8,500 |
| Thompson Tommy G | Director |
Feb 18 '25 |
Option Exercise |
0.00 |
8,500 |
0 |
14,454 |
| Walker Marlan D | Chief Executive Officer |
Feb 18 '25 |
Option Exercise |
0.00 |
8,281 |
0 |
70,846 |
1.19%
0.83%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):